- Home
- DRIO
DRIO
DarioHealth Corp.
as 10-04-2024 4:00pm EST
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 25.1M | IPO Year: | N/A |
| Target Price: | $4.00 | AVG Volume (30 days): | 123.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.68 - $3.32 | Next Earning Date: | 10-31-2024 |
| Revenue: | $19,147,000 | Revenue Growth: | -28.11% |
| Revenue Growth (this year): | 36.4% | Revenue Growth (next year): | 35.93% |
Stock Insider Trading Activity of DarioHealth Corp. (DRIO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nelson Steven Charles | DRIO | Chief Commercial Officer | Sep 10 '24 | Buy | $0.82 | 10,000 | $8,243.50 | 45,000 | |
| Nelson Steven Charles | DRIO | Chief Commercial Officer | Sep 5 '24 | Buy | $0.82 | 15,000 | $12,291.50 | 45,000 | |
| Raphael Erez | DRIO | Chief Executive Officer | Aug 27 '24 | Buy | $0.88 | 5,000 | $4,400.00 | 1,937,059 | |
| Raphael Erez | DRIO | Chief Executive Officer | Aug 20 '24 | Buy | $0.94 | 10,000 | $9,400.00 | 1,937,059 | |
| Nelson Steven Charles | DRIO | Chief Commercial Officer | Aug 19 '24 | Buy | $0.93 | 10,000 | $9,283.00 | 45,000 | |
| Raphael Erez | DRIO | Chief Executive Officer | Aug 16 '24 | Buy | $0.90 | 10,000 | $8,980.00 | 1,937,059 |
Latest DarioHealth Corp. News
DRIO Breaking Stock News: Dive into DRIO Ticker-Specific Updates for Smart Investing
Argus Research
a day ago
Daily – Vickers Top Insider Picks for 10/04/2024
Argus Research
2 days ago
Daily – Vickers Top Insider Picks for 10/03/2024
Zacks
2 days ago
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Zacks
3 days ago
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
Argus Research
3 days ago
Daily – Vickers Top Insider Picks for 10/02/2024
PR Newswire
4 days ago
National Medicare Health Plan Partners with Twill by Dario to Promote Healthy Aging with New Digital Mental Health Benefits for Seniors
Argus Research
4 days ago
Daily – Vickers Top Insider Picks for 10/01/2024
Argus Research
5 days ago
Daily – Vickers Top Insider Picks for 09/30/2024
Compare DRIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRIO DarioHealth Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.